Noggin levels in nonalcoholic fatty liver disease: the effect of vitamin E treatment.
CONCLUSIONS: Lower noggin levels were observed in NAFLD patients than in controls. Noggin levels increased similarly by either combined low-dose spironolactone plus vitamin E or vitamin E monotherapy.
TRIAL REGISTRATION: NCT01147523.
PMID: 30467685 [PubMed - as supplied by publisher]
Source: Hormones - Category: Endocrinology Tags: Hormones (Athens) Source Type: research
More News: Endocrinology | Fatty Liver Disease (FLD) | Hormones | Liver | Liver Disease | Non-alcoholic Fatty Liver Diseases (NAFLD) | Spironolactone | Study | Urology & Nephrology | Vitamin E | Vitamins